Press releases
Nolsterby Invest AB, controlled by Board members Erik Hedlund and Anders Hedlund, has bought shares on April 15 corresponding to ...
Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Company"), took place today, Wednesday, April 16, ...
Pharmacolog i Uppsala AB (publ) announces today that the annual report for the financial year 2023 has been published.
Nolsterby Invest AB, controlled by Board members Erik Hedlund and Anders Hedlund, has during the period April 2-April 5 ...
The Board has decided to appoint Anders Hedlund as interim CEO of the company. He replaces thereby Lars Gusch who ...
The shareholders of Pharmacolog i Uppsala AB (publ), reg. no. 556723-6418 (the "Company"), are hereby invited to an extraordinary ...
The Board of Directors has decided to proceed with the previously communicated business change. Against this background, Pharmacolog will convene ...
The company has decided by mutual agreement that Lars Gusch will step down from his current position as CEO on ...
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...